We narrowed to 3,452 results for: ttl

1. pJB51

   Plasmid

   #226308

   Purpose

   E. coli and H. neapolitanus shuttle vector; integrates the gene of interest and a kanamycin resistance marker into a neutral site on the H. neapolitanus genome.

   Depositor

   David Savage

   Article

   Turnsek et al J Biol Chem. 2024 Jul 4;300(8):107532. d

   Insert

   CsoS2 with V(T/S)G to AAA CsoS2 MR1
   

   Expression

   Bacterial

   Mutation

   VTG273-275AAA, VTG284-286AAA, VTG295-297AAA

   Promoter

   pTRC

   Available Since

   Oct. 21, 2024

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

2. pJB48

   Plasmid

   #226307

   Purpose

   E. coli and H. neapolitanus shuttle vector; integrates the gene of interest and a kanamycin resistance marker into a neutral site on the H. neapolitanus genome.

   Depositor

   David Savage

   Article

   Turnsek et al J Biol Chem. 2024 Jul 4;300(8):107532. d

   Insert

   CsoS2 with C to S CsoS2 MR1-6
   

   Expression

   Bacterial

   Mutation

   C292S, C310S, C351S, C369S, C467S, C485S, C526S, …

   Promoter

   pTRC

   Available Since

   Oct. 21, 2024

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

3. pJB47

   Plasmid

   #226306

   Purpose

   E. coli and H. neapolitanus shuttle vector; integrates the gene of interest and a kanamycin resistance marker into a neutral site on the H. neapolitanus genome.

   Depositor

   David Savage

   Article

   Turnsek et al J Biol Chem. 2024 Jul 4;300(8):107532. d

   Insert

   CsoS2 with C to S CsoS2 MR1-5
   

   Expression

   Bacterial

   Mutation

   C292S, C310S, C351S, C369S, C467S, C485S, C526S, …

   Promoter

   pTRC

   Available Since

   Oct. 21, 2024

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

4. pJB46

   Plasmid

   #226305

   Purpose

   E. coli and H. neapolitanus shuttle vector; integrates the gene of interest and a kanamycin resistance marker into a neutral site on the H. neapolitanus genome.

   Depositor

   David Savage

   Article

   Turnsek et al J Biol Chem. 2024 Jul 4;300(8):107532. d

   Insert

   CsoS2 with C to S CsoS2 MR1-4
   

   Expression

   Bacterial

   Mutation

   C292S, C310S, C351S, C369S, C467S, C485S

   Promoter

   pTRC

   Available Since

   Oct. 21, 2024

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

5. pJB45

   Plasmid

   #226304

   Purpose

   E. coli and H. neapolitanus shuttle vector; integrates the gene of interest and a kanamycin resistance marker into a neutral site on the H. neapolitanus genome.

   Depositor

   David Savage

   Article

   Turnsek et al J Biol Chem. 2024 Jul 4;300(8):107532. d

   Insert

   CsoS2 with C to S CsoS2 MR1-2
   

   Expression

   Bacterial

   Mutation

   C292S, C310S, C351S, C369S

   Promoter

   pTRC

   Available Since

   Oct. 21, 2024

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

6. pJBM2

   Plasmid

   #225289

   Purpose

   E. coli-Campylobacter shuttle vector; KanR

   Depositor

   Robert Moore

   Article

   McDonald et al mBio. 2024 Jul 29:e0110124. doi: 10.1128

   Insert

   Replication elements from pCC311 for pJBM2
   

   Expression

   Bacterial

   Available Since

   Oct. 7, 2024

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

7. Leu2 2u

   Plasmid

   #220622

   Purpose

   empty backbone for shuttle vector construction

   Depositor

   Marvin Wickens

   Article

   Preston et al Nat Methods. 2019 May;16(5):437-445. doi

   Insert

   empty vector (LEU2 Budding Yeast)
   

   Expression

   Yeast

   Available Since

   June 21, 2024

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

8. pDONR221 msNLRP3(ΔPYD, I125M-END) (STOP)

   Plasmid

   #218640

   Purpose

   Gateway shuttling vector for cloning N-terminal NLRP3(ΔPYD, I125M-END) tags (contains a stop codon)

   Depositor

   Wade Harper

   Article

   Hollingsworth et al bioRxiv 2024.04.19.590338

   Insert

   NLRP3 (Nlrp3 Mouse)
   

   Use

   Gateway entry

   Mutation

   delPYD (I125M-END)

   Available Since

   May 3, 2024

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

9. pDONR221 hNLRP3 R262W (disease-associated mutation)

   Plasmid

   #218647

   Purpose

   Gateway shuttling vector for cloning NLRP3-R262W (no stop codon)

   Depositor

   Wade Harper

   Article

   Hollingsworth et al bioRxiv 2024.04.19.590338

   Insert

   NLRP3 (NLRP3 Human)
   

   Use

   Gateway entry

   Mutation

   R262W

   Available Since

   May 3, 2024

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

10. pDONR221 msNLRP3(ΔPYD, I125M-END)

    Plasmid

    #218641

    Purpose

    Gateway shuttling vector for cloning N- and C-terminal NLRP3(ΔPYD, I125M-END) tags (contains no stop codon)

    Depositor

    Wade Harper

    Article

    Hollingsworth et al bioRxiv 2024.04.19.590338

    Insert

    NLRP3 (Nlrp3 Mouse)
    

    Use

    Gateway entry

    Mutation

    delPYD (I125M-END)

    Available Since

    May 1, 2024

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

11. pMGA

    Plasmid

    #139931

    Purpose

    M. magneticum/E. coli shuttle vector (pMGT and p15A ori)

    Depositor

    Christopher Voigt

    Article

    Schuerle et al ACS Synth Biol. 2020 Feb 21;9(2):392-401

    Insert

    sfGFP
    

    Expression

    Bacterial

    Promoter

    PJ23119

    Available Since

    March 3, 2024

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

12. E1_pENTR_L1-L4_HD_G1333-DddA11'-C

    Plasmid

    #199797

    Purpose

    ptpTALECD_v2 vector assembly, Entry clone 1 with attL1 and L4

    Depositor

    Shin-ichi Arimura

    Article

    Nakazato et al Plant J. 2023 Aug;115(4):1151-1162. doi:

    Insert

    C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor
    

    Use

    Talen

    Available Since

    Feb. 9, 2024

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

13. E1_pENTR_L1-L4_NG_G1333-DddA11'-C

    Plasmid

    #199798

    Purpose

    ptpTALECD_v2 vector assembly, Entry clone 1 with attL1 and L4

    Depositor

    Shin-ichi Arimura

    Article

    Nakazato et al Plant J. 2023 Aug;115(4):1151-1162. doi:

    Insert

    C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor
    

    Use

    Talen

    Available Since

    Feb. 9, 2024

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

14. E1_pENTR_L1-L4_NI_G1333-DddA11'-C

    Plasmid

    #199799

    Purpose

    ptpTALECD_v2 vector assembly, Entry clone 1 with attL1 and L4

    Depositor

    Shin-ichi Arimura

    Article

    Nakazato et al Plant J. 2023 Aug;115(4):1151-1162. doi:

    Insert

    C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor
    

    Use

    Talen

    Available Since

    Feb. 9, 2024

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

15. E1_pENTR_L1-L4_NN_G1333-DddA11'-C

    Plasmid

    #199800

    Purpose

    ptpTALECD_v2 vector assembly, Entry clone 1 with attL1 and L4

    Depositor

    Shin-ichi Arimura

    Article

    Nakazato et al Plant J. 2023 Aug;115(4):1151-1162. doi:

    Insert

    C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor
    

    Use

    Talen

    Available Since

    Feb. 9, 2024

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

16. E3_pENTR_L3-L2_HD_G1333-DddA11'-N

    Plasmid

    #199801

    Purpose

    ptpTALECD_v2 vector assembly, Entry clone 3 with attL2 and L3

    Depositor

    Shin-ichi Arimura

    Article

    Nakazato et al Plant J. 2023 Aug;115(4):1151-1162. doi:

    Insert

    C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor
    

    Use

    Talen

    Available Since

    Feb. 9, 2024

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

17. E3_pENTR_L3-L2_NG_G1333-DddA11'-N

    Plasmid

    #199802

    Purpose

    ptpTALECD_v2 vector assembly, Entry clone 3 with attL2 and L3

    Depositor

    Shin-ichi Arimura

    Article

    Nakazato et al Plant J. 2023 Aug;115(4):1151-1162. doi:

    Insert

    C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor
    

    Use

    Talen

    Available Since

    Feb. 9, 2024

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

18. E3_pENTR_L3-L2_NI_G1333-DddA11'-N

    Plasmid

    #199803

    Purpose

    ptpTALECD_v2 vector assembly, Entry clone 3 with attL2 and L3

    Depositor

    Shin-ichi Arimura

    Article

    Nakazato et al Plant J. 2023 Aug;115(4):1151-1162. doi:

    Insert

    C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor
    

    Use

    Talen

    Available Since

    Feb. 9, 2024

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

19. E3_pENTR_L3-L2_NN_G1333-DddA11'-N

    Plasmid

    #199804

    Purpose

    ptpTALECD_v2 vector assembly, Entry clone 3 with attL2 and L3

    Depositor

    Shin-ichi Arimura

    Article

    Nakazato et al Plant J. 2023 Aug;115(4):1151-1162. doi:

    Insert

    C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor
    

    Use

    Talen

    Available Since

    Feb. 9, 2024

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

20. E3_pENTR_L3-L2_HD_G1397-DddA11'-N

    Plasmid

    #191611

    Purpose

    ptpTALECD_v2 vector assembly, Entry clone 3 with attL2 and L3

    Depositor

    Shin-ichi Arimura

    Article

    Nakazato et al Plant J. 2023 Aug;115(4):1151-1162. doi:

    Insert

    C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor
    

    Use

    Other

    Available Since

    Feb. 9, 2024

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge